ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 22 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,762,000 | -4.9% | 1,750,000 | 0.0% | 0.01% | +9.1% |
| Q3 2018 | $1,852,000 | -6.6% | 1,750,000 | 0.0% | 0.01% | -8.3% |
| Q2 2018 | $1,983,000 | -9.5% | 1,750,000 | -12.5% | 0.01% | -7.7% |
| Q1 2018 | $2,190,000 | -5.0% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $2,305,000 | +6.4% | 2,000,000 | 0.0% | 0.01% | +8.3% |
| Q3 2017 | $2,167,000 | +2.8% | 2,000,000 | 0.0% | 0.01% | -7.7% |
| Q2 2017 | $2,109,000 | -0.6% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $2,122,000 | +22.0% | 2,000,000 | +33.3% | 0.01% | +30.0% |
| Q4 2016 | $1,740,000 | -6.2% | 1,500,000 | 0.0% | 0.01% | -9.1% |
| Q3 2016 | $1,856,000 | +13.8% | 1,500,000 | 0.0% | 0.01% | +10.0% |
| Q2 2016 | $1,631,000 | +21.5% | 1,500,000 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $1,342,000 | -7.6% | 1,500,000 | 0.0% | 0.01% | -11.1% |
| Q4 2015 | $1,452,000 | – | 1,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 56,030 | $64,610,000 | 3.40% |
| MANGROVE PARTNERS IM, LLC | 18,779 | $21,537,000 | 2.90% |
| Worth Venture Partners, LLC | 1,102,000 | $1,275,000 | 1.41% |
| DLD Asset Management, LP | 10,250,000 | $11,896,000 | 0.86% |
| Perceptive Advisors | 7,500,000 | $8,642,000 | 0.29% |
| OAKTREE CAPITAL MANAGEMENT LP | 12,719,000 | $14,666,000 | 0.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 3,416,000 | $3,922,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,500,000 | $1,733,000 | 0.06% |
| Certified Advisory Corp | 42,000 | $48,000 | 0.03% |
| CSS LLC/IL | 500,000 | $577,000 | 0.03% |